First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine ; day:11 ; month:6 ; year:2021 ; pages:1-4
Journal of neurology ; (11.6.2021), 1-4
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-021-10648-w
- URN
-
urn:nbn:de:101:1-2021100307344206863021
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Havla, Joachim
- Schultz, Yannick
- Zimmermann, Hanna
- Hohlfeld, Reinhard
- Danek, Adrian
- Kümpfel, Tania
- SpringerLink (Online service)
Other Objects (12)
Impfstoff Pfizer-BioNTech COVID-19 Vaccine
Gram-positive bacteria : vaccine vehicles for mucosal immunization
Pfizer
Evidence of abnormal trading on COVID-19 Pfizer vaccine development information
Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
Reactivation of minimal change disease after Pfizer vaccine against COVID-19
Insights from East and Southern Africa immunization managers on vaccine and immunization research agenda for Africa
Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Combined immunization with inactivated vaccine reduces the dose of live B. abortus A19 vaccine
The lived experiences of a COVID-19 immunization programme: vaccine hesitancy and vaccine refusal
Pfizer, Luise; Kuhn, Maria, geb. Pfizer (USA)
Pfizer, Theodor
Impfstoff Pfizer-BioNTech COVID-19 Vaccine
Gram-positive bacteria : vaccine vehicles for mucosal immunization
Pfizer
Evidence of abnormal trading on COVID-19 Pfizer vaccine development information
Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
Reactivation of minimal change disease after Pfizer vaccine against COVID-19
Insights from East and Southern Africa immunization managers on vaccine and immunization research agenda for Africa
Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Combined immunization with inactivated vaccine reduces the dose of live B. abortus A19 vaccine
The lived experiences of a COVID-19 immunization programme: vaccine hesitancy and vaccine refusal
Pfizer, Luise; Kuhn, Maria, geb. Pfizer (USA)
Pfizer, Theodor
Impfstoff Pfizer-BioNTech COVID-19 Vaccine
Gram-positive bacteria : vaccine vehicles for mucosal immunization
Pfizer
Evidence of abnormal trading on COVID-19 Pfizer vaccine development information
Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
Reactivation of minimal change disease after Pfizer vaccine against COVID-19
Insights from East and Southern Africa immunization managers on vaccine and immunization research agenda for Africa
Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Combined immunization with inactivated vaccine reduces the dose of live B. abortus A19 vaccine
The lived experiences of a COVID-19 immunization programme: vaccine hesitancy and vaccine refusal
Pfizer, Luise; Kuhn, Maria, geb. Pfizer (USA)